United States · FDA National Drug Code directory
Lorazepam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62559-196_f94c8e8d-899c-4eb4-8272-9054155896ec
- Product NDC
- 62559-196
- Form
- TABLET
- Composition / generic term
- Lorazepam
- Labeler
- ANI Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20241201
- Source listing expiry
- 20271231
Source-listed ingredients
- LORAZEPAM — 1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (62559-196-01) · 62559-196-01
- 500 TABLET in 1 BOTTLE (62559-196-05) · 62559-196-05
- 1000 TABLET in 1 BOTTLE (62559-196-10) · 62559-196-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →